## **Core Concept**
The question tests knowledge of opportunistic infections in immunocompromised patients, specifically those related to organ transplantation. After organ transplantation, patients are placed on immunosuppressive therapy to prevent graft rejection, which increases their susceptibility to various infections. The clinical presentation of bilateral diffuse interstitial pneumonia in a transplant patient suggests an opportunistic infection.
## **Why the Correct Answer is Right**
The correct answer, **C. Cytomegalovirus (CMV)**, is a common cause of pneumonia in immunocompromised patients, especially those who have undergone organ transplantation. CMV pneumonia typically presents with fever, cough, and bilateral interstitial infiltrates on chest radiography. CMV is a herpesvirus that can reactivate from latent infection in seropositive individuals or be acquired from the donor organ in seronegative recipients. The timeframe of two months post-transplantation is consistent with CMV infection, which often occurs within the first few months after transplantation.
## **Why Each Wrong Option is Incorrect**
- **Option A:** While *Pneumocystis jirovecii* can cause bilateral interstitial pneumonia, it is more commonly associated with HIV/AIDS or patients on long-term corticosteroids and less potent immunosuppressive regimens. The presentation might be similar, but the context and specific vulnerability to *Pneumocystis* usually differ.
- **Option B:** *Mycoplasma pneumoniae* typically causes mild community-acquired pneumonia and is less likely to cause severe bilateral interstitial pneumonia in an immunocompromised host, especially one who has undergone organ transplantation.
- **Option D:** *Aspergillus* species can cause pneumonia in immunocompromised patients, often presenting as focal lesions or with a more nodular pattern on imaging, rather than bilateral diffuse interstitial pneumonia.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that CMV infection is a significant concern in transplant recipients, and prophylaxis against CMV is often provided to high-risk patients. The clinical presentation of CMV pneumonia can be non-specific, making a high index of suspicion and early diagnostic testing crucial. Prophylactic antiviral therapy, such as valganciclovir, is commonly used in the transplant population to prevent CMV disease.
## **Correct Answer:** . **C. Cytomegalovirus (CMV)**
Free Medical MCQs Β· NEET PG Β· USMLE Β· AIIMS
Access thousands of free MCQs, ebooks and daily exams.
By signing in you agree to our Privacy Policy.